Last reviewed · How we verify

Compound lidocaine — Competitive Intelligence Brief

Compound lidocaine (Compound lidocaine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesia.

marketed Local anesthetic Voltage-gated sodium channels Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Compound lidocaine (Compound lidocaine) — Tianjin Medical University General Hospital. Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Compound lidocaine TARGET Compound lidocaine Tianjin Medical University General Hospital marketed Local anesthetic Voltage-gated sodium channels
levobupivacaine bolus dosing levobupivacaine bolus dosing Kuopio University Hospital marketed Local anesthetic (amide) Voltage-gated sodium channels
Topical anesthetic Topical anesthetic University of Campinas, Brazil marketed Local anesthetic Voltage-gated sodium channels
Lidocaine 5% patch Lidocaine 5% patch Beijing Tiantan Hospital marketed Local anesthetic Voltage-gated sodium channels
Buffered Articaine Hydrochloride + Epinephrine Buffered Articaine Hydrochloride + Epinephrine Ohio State University marketed Local anesthetic with vasoconstrictor Voltage-gated sodium channels; alpha-1 adrenergic receptors (epinephrine component)
Articaine Hydrochloride + Epinephrine Articaine Hydrochloride + Epinephrine Ankara Yildirim Beyazıt University marketed Local anesthetic with vasoconstrictor Voltage-gated sodium channels; alpha-1 adrenergic receptors (epinephrine component)
carbamazepine oxcarbazepine carbamazepine oxcarbazepine Odense University Hospital marketed Anticonvulsant / Antiepileptic agent Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

  1. University of California, San Diego · 3 drugs in this class
  2. Durect · 3 drugs in this class
  3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
  4. Wake Forest University Health Sciences · 3 drugs in this class
  5. Medical University of Vienna · 3 drugs in this class
  6. Imperial College London · 2 drugs in this class
  7. Hvidovre University Hospital · 2 drugs in this class
  8. Innocoll · 2 drugs in this class
  9. George Washington University · 2 drugs in this class
  10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Compound lidocaine — Competitive Intelligence Brief. https://druglandscape.com/ci/compound-lidocaine. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing